Angeles Fernández‐Rodríguez

Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study

Srđan Verstovšek, Aaron T. Gerds, Alessandro M. Vannucchi et al. · The Lancet · 2023 · 164 citations

Hematological Malignancy, Bone Marrow Failure, Momelotinib Versus Danazol +6

Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopenia

Tomás José González‐López, Cristina Pascual, María Román et al. · American Journal of Hematology · 2014 · 148 citations · Full text

Immunohematology, Immunodeficiencies, Immunology +23

Quantifying Mesenchymal Stem Cells in the Mononuclear Cell Fraction of Bone Marrow Samples Obtained for Cell Therapy

María Álvarez‐Viejo, Yolanda Menéndez-Menéndez, Miguel Ángel Blanco-Gelaz et al. · Transplantation Proceedings · 2013 · 115 citations

Regenerative Medicine, Mesenchymal Stem Cells, Cell Therapy +14

Repair of long-bone pseudoarthrosis with autologous bone marrow mononuclear cells combined with allogenic bone graft

Ignacio Fernandez-Bances, Marcos Pérez‐Basterrechea, Silvia Pérez-López et al. · Cytotherapy · 2013 · 52 citations

Regenerative Medicine, Long-bone Pseudoarthrosis, Bone Marrow Failure +12

Efficacy and safety of eltrombopag in persistent and newly diagnosed ITP in clinical practice

Tomás José González‐López, Fernando Fernández‐Fuertes, José‐Ángel Hernández‐Rivas et al. · International Journal of Hematology · 2017 · 52 citations

Clinical Trials, Pathology, Translational Research +3